Reported 30 days ago
Investors should consider selling Walgreens Boots Alliance stock as the company's fundamental investment thesis has failed. Over the past decade, the stock has seen an over 80% decline in total return and a significant cut in dividends. While competitors like CVS Health have fared better, Walgreens faces challenges from declining nonprescription sales, reimbursement issues, and ongoing debt commitments. Given the lack of immediate recovery prospects, it's advisable to exit the investment now and seek more promising opportunities.
Source: YAHOO